Entero Therapeutics Inc. (ENTO)
NASDAQ: ENTO
· Real-Time Price · USD
3.15
0.85 (36.96%)
At close: Sep 12, 2025, 3:59 PM
3.14
-0.32%
After-hours: Sep 12, 2025, 07:52 PM EDT
Entero Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.43 | -1.36 | -0.18 | -0.45 | -0.22 | 1.01 | -0.27 | -0.48 | -0.65 | -1.13 | -1.15 | 0.40 | -0.6 | -1.28 | -1.44 | -0.65 | -5.18 | -7.24 |
PEG Ratio | 0.06 | 0.02 | -0.00 | 0.01 | 0.00 | -0.01 | -0.01 | 0.01 | -0.2 | 0.02 | 0.01 | -0.00 | 0.01 | 0.07 | 0.02 | -0.00 | 0.36 | 0.09 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.10 | 0.12 | 0.15 | 0.07 | 0.11 | 0.29 | 1.25 | 2.01 | 12.36 | 6.76 | 6.68K | -3.12 | -0.92 | -5.35 | -8.23 | -11.3 | 27.31K | 15.45K |
P/FCF Ratio | -104.19 | -8.38 | -51.83 | -2.54 | -2.23 | -5.98 | -1.14 | -1.98 | -3.95 | -6.44 | -3.27K | -1.67 | -2.85 | -6.25 | -10.99 | -3.03 | -33.74K | -43.86K |
P/OCF Ratio | -104.19 | -8.38 | -51.83 | -2.54 | -2.23 | -5.98 | -1.31 | -1.98 | -3.95 | -6.44 | -3.27K | -1.67 | -2.85 | -6.25 | -10.98 | -5.01 | -34.18K | -43.86K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.09 | 0.23 | 0.07 | 0.46 | 0.24 | 0.30 | -0.13 | -0.03 | -0.08 | -0.13 | -0.06 | 0.06 | 0.02 |
Quick Ratio | 2.81 | 2.90 | 3.03 | 5.34 | 5.49 | 1.21 | 1.58 | 1.60 | 0.72 | 0.79 | 38.83 | 0.36 | 0.10 | 0.46 | 0.77 | 0.39 | 1.33 | 3.68 |
Current Ratio | 2.81 | 2.90 | 3.03 | 5.34 | 5.49 | 1.21 | 1.58 | 1.60 | 0.72 | 1.34 | 1.37 | 0.36 | 0.10 | 0.46 | 0.77 | 0.39 | 1.33 | 3.68 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -17.71 | -45.88 | n/a | n/a | n/a | -139.36 | -580.82 | -2.75K | -807.58 | -452.03 | -0.37 | 5.09 | -1.68 | -1.67 | -3.68 | -40.97 | -3.14 | -1.6 |
Return on Equity | -0.02 | -0.02 | -0.21 | -0.04 | -0.12 | 0.07 | -1.14 | -1.05 | -4.75 | -1.5 | -1.45K | -1.93 | 0.38 | 1.04 | 1.43 | 4.36 | -1.32K | -533.69 |
Return on Assets | -0.01 | -0.01 | -0.14 | -0.03 | -0.1 | 0.06 | -0.6 | -0.58 | -0.97 | -0.74 | -732.76 | 0.95 | -1.38 | -1.09 | -0.95 | -2.45 | -673.56 | -427.41 |
Return on Invested Capital | -0.01 | -0.01 | -0.21 | -0.03 | -0.11 | 0.06 | -0.92 | -0.98 | -3.26 | -1.21 | 1.44 | n/a | n/a | n/a | -0.04 | n/a | -0.05 | -0.08 |
Dividend Yield | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | -0.16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |